Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term mutations. Found 79 abstracts

no pagination
Grivennikov SI, Cominelli F. Colitis-Associated and Sporadic Colon Cancers: Different Diseases, Different Mutations?. Gastroenterology. 2016 Apr;150(4):808-10.
Tricarico R, Cortellino S, Riccio A, Jagmohan-Changur S, Van der Klift H, Wijnen J, Turner D, Ventura A, Rovella V, Percesepe A, Lucci-Cordisco E, Radice P, Bertario L, Pedroni M, Ponz de Leon M, Mancuso P, Devarajan K, Cai KQ, Klein-Szanto AJ, Neri G, Moller P, Viel A, Genuardi M, Fodde R, Bellacosa A. Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget. 2015 Oct 16;6(40):42892-904.   PMCID: PMC4767479
Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen XW, Bove B, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P. Identification of fifteen novel germline variants in the BRCA1 3 ' UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Human Mutation. 2012 Dec;33(12):1665-75.
Cauchi C, Somaiah N, Engstrom PF, Litwin S, Lopez M, Lee J, Davey M, Bove B, von Mehren M. Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib. Cancer Chemotherapy and Pharmacology. 2012 Apr;69(4):977-82.   PMCID: PMC3313017
Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O'Farrell M, Cai KQ, Klein-Szanto AJ, Gutkind JS, Hoeflich KP, Chernoff J. p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research. 2012 Nov;72(22):5966-75.   PMCID: PMC3500416
Hammerman PS, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, Getz G, Sougnez C, Imielinski M, Helman E, Hernandez B, Pho NH, Meyerson M, Chu A, Chun HJ, Mungall AJ, Pleasance E, Robertson AG, Sipahimalani P, Stoll D, Balasundaram M, Birol I, Butterfield YS, Chuah E, Coope RJ, Corbett R, Dhalla N, Guin R, Hirst AC, Hirst M, Holt RA, Lee D, Li HI, Mayo M, Moore RA, Mungall K, Nip KM, Olshen A, Schein JE, Slobodan JR, Tam A, Thiessen N, Varhol R, Zeng T, Zhao Y, Jones SJ, Marra MA, Saksena G, Cherniack AD, Schumacher SE, Tabak B, Carter SL, Nguyen H, Onofrio RC, Crenshaw A, Ardlie K, Beroukhim R, Winckler W, Protopopov A, Zhang JH, Hadjipanayis A, Lee S, Xi RB, Yang LX, Ren XJ, Zhang HL, Shukla S, Chen PC, Haseley P, Lee E, Chin L, Park PJ, Kucherlapati R, Socci ND, Liang YP, Schultz N, Borsu L, Lash AE, Viale A, Sander C, Ladanyi M, Auman JT, Hoadley KA, Wilkerson MD, Shi Y, Liquori C, Meng SW, Li L, Turman YJ, Topal MD, Tan DH, Waring S, Buda E, Walsh J, Jones CD, Mieczkowski PA, Singh D, Wu J, Gulabani A, Dolina P, Bodenheimer T, Hoyle AP, Simons JV, Soloway MG, Mose LE, Jefferys SR, Balu S, O'Connor BD, Prins JF, Liu J, Chiang DY, Hayes DN, Perou CM, Cope L, Danilova L, Weisenberger DJ, Maglinte DT, Pan F, den Berg DJ, Triche T, Herman JG, Baylin SB, Laird PW, Noble M, Gehlenborg N, DiCara D, Wu CJ, Liu SY, Zou LH, Lin P, Cho J, Nazaire MD, Robinson J, Thorvaldsdottir H, Mesirov J, Sinha R, Ciriello G, Cerami E, Gross B, Jacobsen A, Gao J, Aksoy BA, Weinhold N, Ramirez R, Taylor BS, Antipin Y, Reva B, Shen RL, Mo Q, Seshan V, Paik PK, Akbani R, Zhang NX, Broom BM, Casasent T, Unruh A, Wakefield C, Cason RC, Baggerly KA, Weinstein JN, Haussler D, Benz CC, Stuart JM, Zhu JC, Szeto C, Scott GK, Yau C, Ng S, Goldstein T, Waltman P, Sokolov A, Ellrott K, Collisson EA, Zerbino D, Wilks C, Ma S, Craft B, Du Y, Cabanski C, Walter V, Wu JY, Marron JS, Liu Y, Wang K, Creighton CJ, Zhang YQ, Travis WD, Rekhtman N, Yi J, Aubry MC, Cheney R, Dacic S, Flieder D, Funkhouser W, Illei P, Myers J, Tsao MS, Penny R, Mallery D, Shelton T, Hatfield M, Morris S, Yena P, Shelton C, Sherman M, Paulauskis J, Govindan R, Azodo I, Beer D, Bose R, Byers LA, Carbone D, Chang LW, Chiang D, Chun E, Collisson E, Ding L, Heymach J, Ida C, Johnson B, Jurisica I, Kaufman J, Kosari F, Kwiatkowski D, Maher CA, Mungall A, Pao W, Peifer M, Robertson G, Rusch V, Siegfried J, Stuart J, Thomas RK, Tomaszek S, Vaske C, Weisenberger D, Wheeler D, Wigle DA, Yang P, Zhang JJ, Jensen MA, Sfeir R, Kahn AB, Chu AL, Kothiyal P, Wang Z, Snyder EE, Pontius J, Pihl TD, Ayala B, Backus M, Walton J, Baboud J, Berton DL, Nicholls MC, Srinivasan D, Raman R, Girshik S, Kigonya PA, Alonso S, Sanbhadti RN, Barletta SP, Greene JM, Pot DA, Bandarchi-Chamkhaleh B, Boyd J, Weaver J, Azodo IA, Tomaszek SC, Ida CM, Brock MV, Rogers K, Rutledge M, Brown T, Lee B, Shin J, Trusty D, Dhir R, Siegfried JM, Potapova O, Fedosenko KV, Nemirovich-Danchenko E, Zakowski M, Iacocca MV, Brown J, Rabeno B, Czerwinski C, Petrelli N, Fan Z, Todaro N, Eckman J, Rathmell WK, Thorne LB, Huang M, Boice L, Hill A, Curley E, Morrison C, Gaudioso C, Bartlett JS, Kodeeswaran S, Zanke B, Sekhon H, David K, Juhl H, Van Le X, Kohl B, Thorp R, Tien NV, Van Bang N, Sussman H, Phu BD, Hajek R, PhiHung N, Khan KZ, Muley T, Shaw KR, Sheth M, Yang L, Buetow K, Davidsen T, Demchok JA, Eley G, Ferguson M, Dillon LA, Schaefer C, Guyer MS, Ozenberger BA, Palchik JD, Peterson J, Sofia HJ, Thomson E. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep;489(7417):519-25.   PMCID: PMC3466113
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang XS, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology Biomarkers & Prevention. 2012 Jan;21(1):134-47.   PMCID: PMC3272407
Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao LC, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E. A Phase 2 Trial of Sunitinib in Patients with Advanced Non-clear Cell Renal Cell Carcinoma. European Urology. 2012 Dec;62(6):1013-9.   PMCID: No NIH
Van den Abbeele AI, Gatsonis C, De Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA. ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with F-18-FDG PET and Correlation with Genotype and GLUT4 Expression. Journal of Nuclear Medicine. 2012 Apr;53(4):567-74.
Wang D, Zhang Q, Blanke CD, Demetri GD, Heinrich MC, Watson JC, Hoffman JP, Okuno S, Kane JM, von Mehren M, Eisenberg BL. Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132. Annals of Surgical Oncology. 2012 Apr;19(4):1074-80.
Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, Dhir R, DiSaia P, Gabra H, Glenn P, Godwin AK, Gross J, Hartmann L, Huang M, Huntsman DG, Iacocca M, Imielinski M, Kalloger S, Karlan BY, Levine DA, Mills GB, Morrison C, Mutch D, Olvera N, Orsulic S, Park K, Petrelli N, Rabeno B, Rader JS, Sikic BI, Smith-McCune K, Sood AK, Bowtell D, Penny R, Testa JR, Chang K, Dinh HH, Drummond JA, Fowler G, Gunaratne P, Hawes AC, Kovar CL, Lewis LR, Morgan MB, Newsham IF, Santibanez J, Reid JG, Trevino LR, Wu YQ, Wang M, Muzny DM, Wheeler DA, Gibbs RA, Getz G, Lawrence MS, Cibulskis K, Sivachenko AY, Sougnez C, Voet D, Wilkinson J, Bloom T, Ardlie K, Fennell T, Baldwin J, Gabriel S, Lander ES, Ding L, Fulton RS, Koboldt DC, McLellan MD, Wylie T, Walker J, O'Laughlin M, Dooling DJ, Fulton L, Abbott R, Dees ND, Zhang Q, Kandoth C, Wendl M, Schierding W, Shen D, Harris CC, Schmidt H, Kalicki J, Delehaunty KD, Fronick CC, Demeter R, Cook L, Wallis JW, Lin L, Magrini VJ, Hodges JS, Eldred JM, Smith SM, Pohl CS, Vandin F, Raphael BJ, Weinstock GM, Mardis R, Wilson RK, Meyerson M, Winckler W, Verhaak RG, Carter SL, Mermel CH, Saksena G, Nguyen H, Onofrio RC, Hubbard D, Gupta S, Crenshaw A, Ramos AH, Chin L, Protopopov A, Zhang JH, Kim TM, Perna I, Xiao Y, Zhang H, Ren G, Sathiamoorthy N, Park RW, Lee E, Park PJ, Kucherlapati R, Absher DM, Waite L, Sherlock G, Brooks JD, Li JZ, Xu J, Myers RM, Laird PW, Cope L, Herman JG, Shen H, Weisenberger DJ, Noushmehr H, Pan F, Triche T, Berman BP, Van den Berg DJ, Buckley J, Baylin SB, Spellman PT, Purdom E, Neuvial P, Bengtsson H, Jakkula LR, Durinck S, Han J, Dorton S, Marr H, Choi YG, Wang V, Wang NJ, Ngai J, Conboy JG, Parvin B, Feiler HS, Speed TP, Gray JW, Socci ND, Liang Y, Taylor BS, Schultz N, Borsu L, Lash AE, Brennan C, Viale A, Sander C, Ladanyi M, Hoadley KA, Meng S, Du Y, Shi Y, Li L, Turman YJ, Zang D, Helms EB, Balu S, Zhou X, Wu J, Topal MD, Hayes DN, Perou CM, Zhang JN, Wu CJ, Shukla S, Sivachenko A, Jing R, Liu Y, Noble M, Carter H, Kim D, Karchin R, Korkola JE, Heiser LM, Cho RJ, Hu Z, Cerami E, Olshen A, Reva B, Antipin Y, Shen R, Mankoo P, Sheridan R, Ciriello G, Chang WK, Bernanke JA, Haussler D, Benz CC, Stuart JM, Benz SC, Sanborn JZ, Vaske CJ, Zhu J, Szeto C, Scott GK, Yau C, Wilkerson MD, Zhang N, Akbani R, Baggerly KA, Yung WK, Weinstein JN, Shelton T, Grimm D, Hatfield M, Morris S, Yena P, Rhodes P, Sherman M, Paulauskis J, Millis S, Kahn A, Greene JM, Sfeir R, Jensen MA, Chen J, Whitmore J, Alonso S, Jordan J, Chu A, Barker A, Compton C, Eley G, Ferguson M, Fielding P, Gerhard DS, Myles R, Schaefer C, Shaw KR, Vaught J, Vockley JB, Good PJ, Guyer MS, Ozenberger B, Peterson J, Thomson E, Canc Genome Atlas Res Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun;474(7353):609-15.   PMCID: PMC3163504
Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGF beta-mediated transcription. Oncogene. 2011 Jun;30(22):2534-46.   PMCID: PMC3109270
Frank AK, Pietsch EC, Dumont P, Tao J, Murphy ME. Wild-type and mutant p53 proteins interact with mitochondrial caspase-3. Cancer Biology & Therapy. 2011 Apr;11(8):740-5.   PMCID: PMC3100564
Huang J, Zhang L, Greshock J, Colligon TA, Wang Y, Ward R, Katsaros D, Lassus H, Butzow R, Godwin AK, Testa JR, Nathanson KL, Gimotty PA, Coukos G, Weber BL, Degenhardt Y. Frequent Genetic Abnormalities of the PI3K/AKT Pathway in Primary Ovarian Cancer Predict Patient Outcome. Genes Chromosomes & Cancer. 2011 Aug;50(8):606-18.   PMCID: PMC3110626
Huson SM, Acosta MT, Belzberg AJ, Bernards A, Chernoff J, Cichowski K, Evans DG, Ferner RE, Giovannini M, Korf BR, Listernick R, North KN, Packer RJ, Parada LF, Peltonen J, Ramesh V, Reilly KM, Risner JW, Schorry EK, Upadhyaya M, Viskochil DH, Zhu YA, Hunter-Schaedle K, Giancotti FG. Back to the Future: Proceedings From the 2010 NF Conference. American Journal of Medical Genetics Part A. 2011 Feb;155A(2):307-21.   PMCID: PMC3079924
Ilson DH, Kelsen D, Shah M, Schwartz G, Levine DA, Boyd J, Capanu M, Miron B, Klimstra D. A Phase 2 Trial of Erlotinib in Patients With Previously Treated Squamous Cell and Adenocarcinoma of the Esophagus. Cancer. 2011 Apr;117(7):1409-14.   PMCID: PMC3116987
Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, McBryan T, Doyle B, McKay C, Oien KA, Enders GH, Zhang RG, Sansom OJ, Adams PD. Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis. Mol Cell. 2011 Apr;42(1):36-49.
Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene. 2011 Jun;30(23):2633-43.   PMCID: PMC164309
Nie H, Evans AA, London WT, Block TM, Ren XD. Ultrasensitive Quantification of Hepatitis B Virus A1762T/G1764A Mutant by a SimpleProbe PCR Using a Wild-Type-Selective PCR Blocker and a Primer-Blocker-Probe Partial-Overlap Approach. Journal of Clinical Microbiology. 2011 Jul;49(7):2440-8.   PMCID: PMC3147845
De Keersmaecker K, Real PJ, Della Gatta G, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, Pandolfi PP, Kappes D, Gounari F, Petrie H, Van der Meulen J, Speleman F, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Soulier J, Avran D, Cave H, Dastugue N, Raimondi S, Meijerink JP, Cordon-Cardo C, Califano A, Ferrando AA. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature medicine. 2010 Nov;16(11):1321-7.   PMCID: PMC2974790
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term mutations

mutations expression carcinoma risk growth gist GIST management pathway therapy kit p53 women growth-factor receptor gefitinib phenotype survival tumorigenesis tumors cancer dna-binding domain lymphomagenesis interferon-alpha in-vivo mek inhibitor pd0325901 neurofibromatosis type-2 germline pten expression FDG-PET gene-expression progression temsirolimus breast cancer BRCA1-3 ' UTR-microRNAs mutant-cells family registry copy-number alteration colitis binding protein hur combination pro-caspase-3 breast-cancer squamous-cell carcinomas fdg-pet eortc-soft-tissue akt transgenic mice papillary apoptosis Tyrosine kinase inhibitor whole exome sequencing gene fusion colorectal-cancer immunohistochemical markers kinase peripheral-nerve solid tumors Mbd4 notch1 lung-cancer estrogen-receptor status squamous cancer esophageal cancer-erlotinib-response evaluation med1 transcriptional regulation mismatch repair signaling pathways growth arrest Nilotinib bone-sarcoma-group Sunitinib Non-clear cell renal cell carcinoma-Targeted therapy-Renal cell carcinoma variant histology-Papillary renal cell carcinoma-Chromophobe renal cell carcinoma adenocarcinoma mesylate epidemiology associations mitochondria gastrointestinal stromal tumors human-diseases gastroesophageal junction lymphocytes cancer statistics glioblastoma viral load spred1 bhd gene identification positron-emission-tomography 2008 rbes sa-pch10 amplification pak protein-kinases high-throughput annotation epithelial-cells carcinomas signaling tumor subtypes therapeutic target complex features colorectal cancer copy number grade serous schwannomatosis neurofibromatosis-NF1-NF2-neurofibroma-learning disabilities-bone dysplasia-MPNST in-vitro hybrid selection Wnt signaling HEF1-colorectal cancer-tumorigenesis core-promoter yolk-sac bcl11b susceptibility gene conditional expression therapeutic response early prediction sorafenib somatic prostaglandin e-2 carriers pathways bh3-only protein bim mtor activation infection gynecologic-oncology-group resection Kit mutations caspase-3 renal-cell carcinoma caspase-9 increase comparative genomic hybridization iii trial diagnosis apoptosis BHD-Bim-TGF beta-mTOR permeabilization brca mutation carriers hox11 Secondary tumor bak plexiform e-antigen seroconversion 1995 en cya-trends in biochemical sciences-v20-p465 endothelial growth-factor Hnpcc met protooncogene k-ras hepatocellular-carcinoma double-blind genome-wide association beta-catenin cellular senescence ductal pancreatic-cancer GLUT4
Last updated on Sunday, July 05, 2020